Aptar Group said its intranasal medical delivery technology will be used to administer Cardamyst, a treatment for paroxysmal supraventricular tachycardia in adults.

Jonathan Haigh, Head of UK Sites, FUJIFILM Biotechnologies, explores how advanced technologies are being used to reduce risk ...

Dong-A Socio Group is targeting the global market with a diversified strategy encompassing new drug development, raw ...

Andrew Anderson shares insights on the factors that may shape the next major advance in pharmaceutical informatics strategy.

The CNPV program significantly reduces drug review times, necessitating operational shifts for sponsors to meet compressed ...

Targeted patient recruitment can increase the likelihood of trial success and help cultivate use of precision medicine.

BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 ...

The evolution from time-consuming manual reviews to automated detection and now to intelligent action is reimagining the ...

The company's next generation barrier technology is designed to support stability, efficiency, and sustainability goals.PARIS, Dec. 16, 2025 /PRNewswire/ ...

MoUs worth ₹6,263 crore were signed at the Odisha Pharma Summit 2025, boosting pharma, med-tech investments and creating over ...

Based on research and analysis of the global microecology market, as well as the evaluation of relevant companies in the ...

Phoenix Controls helps safely and efficiently manage sterile airflow control and room pressure in clean rooms with its ...